Identification of an HLA‐A*24:02‐restricted α ‐fetoprotein signal peptide‐derived antigen and its specific T‐cell receptor for T‐cell immunotherapy
出版年份 2019 全文链接
标题
Identification of an HLA‐A*24:02‐restricted
α
‐fetoprotein signal peptide‐derived antigen and its specific T‐cell receptor for T‐cell immunotherapy
作者
关键词
-
出版物
IMMUNOLOGY
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2019-12-18
DOI
10.1111/imm.13168
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Immunotherapy in hepatocellular carcinoma
- (2019) Luigi Buonaguro et al. Annals of Hepatology
- Immune cell therapy for hepatocellular carcinoma
- (2019) Eishiro Mizukoshi et al. Journal of Hematology & Oncology
- Randomized trials and endpoints in advanced HCC: Role of PFS as a surrogate of survival
- (2019) Josep M. Llovet et al. JOURNAL OF HEPATOLOGY
- Current perspectives on the immunosuppressive tumor microenvironment in hepatocellular carcinoma: challenges and opportunities
- (2019) Chen Lu et al. Molecular Cancer
- Identification of α-fetoprotein-specific T-cell receptors for hepatocellular carcinoma immunotherapy
- (2018) Wei Zhu et al. HEPATOLOGY
- Preclinical Strategies to Identify Off-Target Toxicity of High-Affinity TCRs
- (2018) Helena M. Bijen et al. MOLECULAR THERAPY
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Tuning T cell receptor affinity to optimize clinical risk-benefit when targeting α-fetoprotein-positive liver cancer
- (2018) Roslin Y. Docta et al. HEPATOLOGY
- Association Between High-Avidity T-Cell Receptors, Induced by α-Fetoprotein−Derived Peptides, and Anti-Tumor Effects in Patients With Hepatocellular Carcinoma
- (2017) Hidetoshi Nakagawa et al. GASTROENTEROLOGY
- Targeting naturally occurring epitope variants of hepatitis C virus with high-affinity T-cell receptors
- (2017) Huajun Zhang et al. JOURNAL OF GENERAL VIROLOGY
- Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
- (2017) Anthony B El-Khoueiry et al. LANCET
- The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level
- (2017) et al. JAMA Oncology
- Cancer statistics in China, 2015
- (2016) Wanqing Chen et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Targeting Alpha-Fetoprotein (AFP)–MHC Complex with CAR T-Cell Therapy for Liver Cancer
- (2016) Hong Liu et al. CLINICAL CANCER RESEARCH
- Mass spectrometry-based antigen discovery for cancer immunotherapy
- (2016) Michal Bassani-Sternberg et al. CURRENT OPINION IN IMMUNOLOGY
- T-cell adoptive immunotherapy using tumor-infiltrating T cells and genetically engineered TCR-T cells: Table 1.
- (2016) Hiroaki Ikeda INTERNATIONAL IMMUNOLOGY
- Effect of HCV clearance with direct-acting antiviral agents on HCC
- (2016) Josep M. Llovet et al. Nature Reviews Gastroenterology & Hepatology
- NetMHCpan-3.0; improved prediction of binding to MHC class I molecules integrating information from multiple receptor and peptide length datasets
- (2016) Morten Nielsen et al. Genome Medicine
- Cancer Neoantigens and Applications for Immunotherapy
- (2015) A. Desrichard et al. CLINICAL CANCER RESEARCH
- TCR affinity for p/MHC formed by tumor antigens that are self-proteins: impact on efficacy and toxicity
- (2015) Jennifer D Stone et al. CURRENT OPINION IN IMMUNOLOGY
- Distribution of HLA haplotypes across Japanese Archipelago: similarity, difference and admixture
- (2015) Hirofumi Nakaoka et al. JOURNAL OF HUMAN GENETICS
- Identifying Individual T Cell Receptors of Optimal Avidity for Tumor Antigens
- (2015) Michael Hebeisen et al. Frontiers in Immunology
- Alternative Antigen Processing for MHC Class I: Multiple Roads Lead to Rome
- (2015) Cláudia C. Oliveira et al. Frontiers in Immunology
- The use of signal peptide domains as vaccine candidates
- (2014) Riva Kovjazin et al. Human Vaccines & Immunotherapeutics
- T-cell receptor affinity and avidity defines antitumor response and autoimmunity in T-cell immunotherapy
- (2013) S. Zhong et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Identification of a Titin-Derived HLA-A1-Presented Peptide as a Cross-Reactive Target for Engineered MAGE A3-Directed T Cells
- (2013) B. J. Cameron et al. Science Translational Medicine
- Different affinity windows for virus and cancer-specific T-cell receptors: Implications for therapeutic strategies
- (2012) Milos Aleksic et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Tumor Regression in Patients With Metastatic Synovial Cell Sarcoma and Melanoma Using Genetically Engineered Lymphocytes Reactive With NY-ESO-1
- (2011) Paul F. Robbins et al. JOURNAL OF CLINICAL ONCOLOGY
- Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen
- (2009) L. A. Johnson et al. BLOOD
- IRF-1 and p65 mediate upregulation of constitutive HLA-A antigen expression by hepatocellular carcinoma cells
- (2009) Yuqing Shen et al. MOLECULAR IMMUNOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started